University Cancer & Blood Center

UCBC is the first cancer center in Georgia to offer Theranostics treatment outside of a hospital setting.

Theranostics


TheranosticsWhat is Theranostics?

Theranostics is a personalized approach to treating cancer, using both diagnostics (imaging) and therapy tools as part of the treatment. Custom Theranostic treatment plans can be devised that are unique to each individual, ensuring that the most effective treatment is administered at the right time.

How does it work?

Theranostics uses PET scan imaging to see if specific targets, known as tumor receptors, are present on tumor cells. If these targets are present and visible on the scan, a radioactive drug is used to treat the tumors. The drug is given as an injection and selectively targets the tumor cells with precision while avoiding healthy areas.

What types of Theranostics treatments do we offer?

Currently, UCBC is treating adults with Gastroenteropancreatic Neuroendocrine Tumors, also known as GEP NETs” or “neuroendocrine tumor” or “neuroendocrine cancer”, and also men with prostate cancer.

LUTATHERA®

LUTATHERA® (lutetium Lu 177 dotatate) is a prescription medicine used to treat adults with a type of cancer known as gastroenteropancreatic neuroendocrine tumors (GEP-NETs) that are positive for the hormone receptor somatostatin, including GEP-NETs in the foregut, midgut, and hindgut.

Xofigo®

Xofigo® (radium Ra 223 dichloride) injection is used to treat prostate cancer that no longer responds to hormonal or surgical treatment that lowers testosterone. It is for men whose prostate cancer has spread to the bone with symptoms but not to other parts of the body.

Pluvicto®

Pluvicto® (lutetium Lu 177 vipivotide tetraxetan) is indicated for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) who have already been treated with other anticancer treatments. Pluvicto® is a targeted radioligand therapy.

Read the full press release here.


What to expect

INITIAL CONSULTATION

It is important that you feel informed and supported on your Theranostics treatment journey. We are here to answer any questions or concerns you may have. Before treatment commences, your care team will explain the treatment process, treatment options and any potential side effects. You will receive a care plan tailored to your needs. If you have any questions please call our office at (706) 353-2990

REFERRING PHYSICIANS

Patient will be seen for consultation and determined if they are a candidate for the therapy.  If eligible, UCBC  will schedule the patient immediately.  UCBC  will ensure the patient continues to be at your office for regular follow ups and ensure they transition back to your office upon completion of therapy. UCBC will also ensure a copy of the office notes and records are sent to your office  at each treatment visit.  To determine a patient’s eligibility before scheduling an appointment, we will need copies of the most recent office note, treatment history, pathology, PET scan report (if available) and most recent labs.  Call our new patient coordinator(s) (706) 353-2990 to schedule a patient. Our team will return your call within 24 hours.

Our Affiliations

The Cancer FoundationNCIACHC Accredited

We’re Here to Help! Click Below to Get Started

Contact Us Now